Stock DNA
Pharmaceuticals & Biotechnology
CNY 13,248 Million (Large Cap)
NA (Loss Making)
NA
0.00%
-0.28
-3.40%
1.71
Revenue and Profits:
Net Sales:
755 Million
(Quarterly Results - Sep 2025)
Net Profit:
-16 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.16%
0%
-26.16%
6 Months
26.45%
0%
26.45%
1 Year
41.17%
0%
41.17%
2 Years
-23.68%
0%
-23.68%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
MGI Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.30%
EBIT Growth (5y)
-18.14%
EBIT to Interest (avg)
-46.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
0.33
Tax Ratio
8.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
5.52%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.81
EV to EBIT
-18.79
EV to EBITDA
-85.95
EV to Capital Employed
2.23
EV to Sales
3.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.87%
ROE (Latest)
-5.32%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
755.20
659.80
14.46%
Operating Profit (PBDIT) excl Other Income
1.80
-79.30
102.27%
Interest
7.60
7.50
1.33%
Exceptional Items
0.10
0.00
Consolidate Net Profit
-16.40
-165.50
90.09%
Operating Profit Margin (Excl OI)
2.40%
-293.70%
29.61%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 14.46% vs -13.23% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 90.09% vs -63.86% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,003.90
2,903.00
3.48%
Operating Profit (PBDIT) excl Other Income
-200.40
-497.10
59.69%
Interest
25.90
15.30
69.28%
Exceptional Items
-8.60
14.10
-160.99%
Consolidate Net Profit
-609.00
-607.20
-0.30%
Operating Profit Margin (Excl OI)
-199.00%
-287.90%
8.89%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 3.48% vs -31.05% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -0.30% vs -130.01% in Dec 2023
About MGI Tech Co., Ltd. 
MGI Tech Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






